Bristol Myers Squibb (BMY) Change in Taxes (2016 - 2025)
Historic Change in Taxes for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to -$324.0 million.
- Bristol Myers Squibb's Change in Taxes fell 36776.86% to -$324.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.0 million, marking a year-over-year increase of 9968.25%. This contributed to the annual value of -$4.0 million for FY2025, which is 9968.25% up from last year.
- According to the latest figures from Q4 2025, Bristol Myers Squibb's Change in Taxes is -$324.0 million, which was down 36776.86% from $887.0 million recorded in Q3 2025.
- In the past 5 years, Bristol Myers Squibb's Change in Taxes registered a high of $1.0 billion during Q4 2023, and its lowest value of -$2.1 billion during Q2 2023.
- In the last 5 years, Bristol Myers Squibb's Change in Taxes had a median value of -$134.0 million in 2021 and averaged -$217.6 million.
- As far as peak fluctuations go, Bristol Myers Squibb's Change in Taxes tumbled by 222272.73% in 2021, and later surged by 35488.51% in 2025.
- Quarter analysis of 5 years shows Bristol Myers Squibb's Change in Taxes stood at -$222.0 million in 2021, then tumbled by 401.35% to -$1.1 billion in 2022, then surged by 193.8% to $1.0 billion in 2023, then plummeted by 88.41% to $121.0 million in 2024, then plummeted by 367.77% to -$324.0 million in 2025.
- Its Change in Taxes was -$324.0 million in Q4 2025, compared to $887.0 million in Q3 2025 and -$621.0 million in Q2 2025.